Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Paragonix Technologies

Paragonix Launches Initiative to Increase Donor Lung Utilization
From Paragonix Technologies
Via Business Wire
Paragonix Celebrates 100th Kidney Transplant Case with FDA-Cleared KidneyVault™ System
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
From Paragonix Technologies
Via Business Wire
Paragonix Secures EU MDR Approval for Five Organ Preservation Devices
From Paragonix Technologies
Via Business Wire
Paragonix KidneyVault™ Perfusion System Successfully Embarks on First Commercial Flight
From Paragonix Technologies
Via Business Wire
Paragonix Announces World’s First-In-Human Use of KidneyVault Renal Perfusion System
From Paragonix Technologies
Via Business Wire
Paragonix LIVERguard System Shown to Reduce Post-Transplant Complications in Transplant Recipients
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Joins Living Donor Circle of Excellence Offering Paid Leave to Living Donor Employees
From Paragonix Technologies
Via Business Wire
Paragonix BAROguard Earns Spot on TIME’s 2024 Best Inventions List
From Paragonix Technologies
Via Business Wire
Paragonix Announces World’s First-In-Human Use of PancreasPak™ Organ Preservation System by Tampa General Hospital
From Paragonix Technologies
Via Business Wire
HonorBridge Celebrates First Successful Liver Transplant Using Paragonix Advanced LIVERguard® Technology
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Receives FDA 510(k) Clearance for KidneyVault Portable Renal Perfusion System
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Announces First Pediatric Use of BAROguard Lung Preservation System
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Expands Abdominal Research in GUARDIAN Clinical Registries
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Leads New Organ Recovery Initiative to Establish Cost-Effective Transport Alternative
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Signs Definitive Agreement to be Acquired by Getinge
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Launches New Molecular Diagnostics Study to Expand Data Collection in Post-Transplant Monitoring
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Announces First Pediatric Use of LIVERguard Preservation System
From Paragonix Technologies
Via Business Wire
Paragonix Unveils PancreasPak™: The World’s First FDA-Cleared Preservation Device for Donor Pancreas Transplantation
From Paragonix Technologies
Via Business Wire
New International Study Reports Extension of the Donor Lung Transplantation Window
From Paragonix Technologies
Via Business Wire
Paragonix Advanced Organ Preservation Enables Mid-America Transplant to Place High-Risk Donor Livers
From Paragonix Technologies
Via Business Wire
Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Unveils Expansive Organ Procurement Network
From Paragonix Technologies
Via Business Wire
Paragonix Announces World’s First-In-Human Use of BAROguard™ Donor Lung Preservation System by Leading Academic Medical Center
From Paragonix Technologies
Via Business Wire
Paragonix Technologies, Leader in Organ Transplantation, Opens New U.S. Headquarters
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Receives FDA Clearance for BAROguard™ Donor Lung Preservation System
From Paragonix Technologies
Via Business Wire
Paragonix Technologies Sponsors Support Program for Pediatric Transplant Families
From Paragonix Technologies
Via Business Wire
Paragonix Expands Research for Advanced Organ Preservation Clinical Registries
From Paragonix Technologies
Via Business Wire
Paragonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case
From Paragonix Technologies
Via Business Wire
Paragonix Announces First-in-Human use of LIVERguard™ Donor Liver Preservation System by Mayo Clinic
From Paragonix Technologies
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.